Selective Serotonin Reuptake Inhibitors: all 1,366 studies that test it

Page 4 of 14. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.

• Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01355081Phase 3Results posted
• Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive DisorderCompletedNCT01354314Phase 1/2Results posted
• Study of Trazodone & Cognitive Behavioral Therapy to Treat InsomniaCompletedNCT01348542Not applicableResults posted
• Paxil CR Bioequivalence Study Brazil - Fed AdministrationCompletedNCT01339247Phase 1Results posted
• Antidepressant Treatment at an Inner City Asthma ClinicCompletedNCT01324700Phase 4Results posted
• Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in AdultsCompletedNCT01323478Phase 3Results posted
• Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male AdultsCompletedNCT01299805Phase 1Results posted
• A Study in Prevention of Re-emergence of Depression SymptomsCompletedNCT01299272Phase 3Results posted
• Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress DisorderCompletedNCT01271244Phase 4Results posted
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01255787Phase 2/3Results posted
• A Pharmacokinetic Study of the Coadministration of LY2216684 With SertralineCompletedNCT01250873Phase 1Results posted
• 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting ConditionsCompletedNCT01247285Phase 1Results posted
• 90 mg Fluoxetine Hydrochloride Capsules Under Fasting ConditionsCompletedNCT01247272Phase 1Results posted
• Lexapro for Major Depression in Patients With EpilepsyTerminatedNCT01244724Phase 4Results posted
• A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.CompletedNCT01243957Phase 1Results posted
• A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) ConditionsCompletedNCT01235195Phase 1Results posted
• Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive DisorderCompletedNCT01198795Phase 4Results posted
• A Study of Medication With or Without Psychotherapy for Complicated GriefCompletedNCT01179568Phase 2Results posted
• Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01179516Phase 3Results posted
• Olanzapine Versus Placebo for Outpatients With Anorexia NervosaCompletedNCT01170117Not applicableResults posted
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01163266Phase 3Results posted
• A Safety Study in Participants With Major Depressive DisorderCompletedNCT01155661Phase 3Results posted
• Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy SubjectsCompletedNCT01155531Phase 1Results posted
• Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01153009Phase 3Results posted
• Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension StudyCompletedNCT01152996Phase 3Results posted
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsCompletedNCT01140906Phase 3Results posted
• Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) AttackCompletedNCT01130103Phase 4Results posted
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01123707Phase 3Results posted
• A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets at Steady StateCompletedNCT01121926Phase 1Results posted
• Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy VolunteersCompletedNCT01121913Phase 1Results posted
• A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily)CompletedNCT01121900Phase 1Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111565Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111552Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111539Phase 3Results posted
• Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality DisorderTerminatedNCT01103180Phase 2Results posted
• 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor SymptomsCompletedNCT01101841Phase 3Results posted
• The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation TherapyCompletedNCT01063881Phase 3Results posted
• Concomitant Use of PriLigy in Men Treated for Erectile DysfunctionCompletedNCT01063855Phase 3Results posted
• DECIFER: Depression and Citalopram In First Episode RecoveryCompletedNCT01041274Phase 4Results posted
• Antidepressant Controlled Trial for Negative Symptoms in SchizophreniaCompletedNCT01032083Phase 4Results posted
• fMRI Study of Treatment Changes in Major DepressionCompletedNCT01027559Not applicableResults posted
• Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial EpilepsyCompletedNCT00986310Not applicableResults posted
• A Study of Olanzapine in Patients With SchizophreniaCompletedNCT00970281Phase 3Results posted
• Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)CompletedNCT00965562Not applicableResults posted
• Escitalopram (Lexapro) for Depression MS or ALSCompletedNCT00965497Phase 3Results posted
• Anxiety and Recurrent Abdominal Pain in ChildrenCompletedNCT00962039Phase 2/3Results posted
• Prevention of Relapse & Recurrence of Bipolar DepressionCompletedNCT00961961Phase 4Results posted
• Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.TerminatedNCT00958633Phase 3Results posted
• Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant DepressionCompletedNCT00953745Not applicableResults posted
• Chronic Kidney Disease Antidepressant Sertraline TrialCompletedNCT00946998Phase 3Results posted
• Safety and Efficacy of Fluoxetine in Pulmonary Arterial HypertensionCompletedNCT00942708Phase 2Results posted
• Aging Brain Changes, Executive Dysfunction and DepressionCompletedNCT00918684Phase 4Results posted
• Brain Imaging Techniques That Predict Antidepressant ResponsivenessCompletedNCT00909155Not applicableResults posted
• Escitalopram in Patients With Generalized Anxiety DisorderCompletedNCT00902564Phase 4Results posted
• Escitalopram in Patients With Social Anxiety DisorderCompletedNCT00902226Phase 4Results posted
• Citalopram for Agitation in Alzheimer's DiseaseCompletedNCT00898807Phase 3Results posted
• Functional MRI Before and After Treatment for DepressionTerminatedNCT00896441Not applicableResults posted
• Examining the Effects of Antipsychotic Medications on Insulin SensitivityCompletedNCT00895921Phase 4Results posted
• MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife WomenCompletedNCT00894543Not applicableResults posted
• Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDSCompletedNCT00887679Phase 3Results posted
• Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care UnitCompletedNCT00872027Phase 4Results posted
• Paroxetine Hydrochloride 40 mg Tablets Under Fasting ConditionsCompletedNCT00841698Phase 1Results posted
• Paroxetine Hydrochloride 40 mg Tablets Under Fed ConditionsCompletedNCT00841659Phase 1Results posted
• Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsCompletedNCT00839423Phase 2Results posted
• Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult VolunteersCompletedNCT00839072Phase 1Results posted
• Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality DisorderCompletedNCT00834834Phase 4Results posted
• Escitalopram (Lexapro) for the Treatment of Postpartum DepressionCompletedNCT00833469Phase 4Results posted
• Brain Effects of Escitalopram and Citalopram Using fMRICompletedNCT00825825Phase 4Results posted
• Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in DepressionCompletedNCT00824044Phase 4Results posted
• Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)TerminatedNCT00812812Phase 4Results posted
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly PatientsCompletedNCT00811252Phase 3Results posted
• Early Versus Delayed Switch in Medication in Patients With Major Depressive DisorderCompletedNCT00810069Phase 4Results posted
• Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive DisorderCompletedNCT00807248Phase 2Results posted
• Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaCompletedNCT00802100Phase 4Results posted
• Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaCompletedNCT00797277Phase 3Results posted
• Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With MenopauseCompletedNCT00786188Phase 2Results posted
• A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.CompletedNCT00775203Phase 3Results posted
• Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in AdultsCompletedNCT00761306Phase 2Results posted
• Treatment Response of Geriatric DepressionCompletedNCT00754936Not applicableResults posted
• Sinusitis and Facial Pain Disorders Anti-Depression TrialTerminatedNCT00754793Phase 4Results posted
• fMRI Studies of Emotional Brain Circuitry in People With Major DepressionCompletedNCT00749125Not applicableResults posted
• A New Pharmacotherapy for Alcohol Dependence: OlanzapineCompletedNCT00746785Phase 3Results posted
• Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for AnxietyTerminatedNCT00746239Not applicableResults posted
• Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.CompletedNCT00744627Phase 3Results posted
• A Crossover Study of the Acute Effects of Olanzapine in Healthy VolunteersCompletedNCT00741026Not applicableResults posted
• Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT00735709Phase 3Results posted
• An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCompletedNCT00734071Phase 3Results posted
• Clinical Neurobiology of Serotonin and AddictionCompletedNCT00732901Phase 2/3Results posted
• Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCompletedNCT00731120Phase 3Results posted
• Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCompletedNCT00730691Phase 3Results posted
• Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT00707980Phase 3Results posted
• Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on EscitalopramCompletedNCT00707863Phase 4Results posted
• Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain InjuryCompletedNCT00704379Phase 2/3Results posted
• Progression Delaying Effect of Escitalopram in Alzheimer's DiseaseCompletedNCT00702780Not applicableResults posted
• Pharmacological Treatment of Generalized Anxiety Disorder in the ElderlyCompletedNCT00701675Phase 4Results posted
• Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)CompletedNCT00700999Phase 4Results posted
• Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in AdultsCompletedNCT00694304Phase 3Results posted
• Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia NervosaCompletedNCT00692185Phase 2Results posted
• Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia NervosaCompletedNCT00685334Phase 4Results posted
• Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)CompletedNCT00683592Phase 3Results posted

← Selective Serotonin Reuptake Inhibitors overview